Flumethasone Pivalate

CHEMBL1200877 Phase 4 Aprovado Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

494.6 g/mol

LogP

3.9

Phase

4

This topical corticosteroid is applied to the skin or used in ear preparations to reduce inflammation, itching, and redness associated with inflammatory skin or ear conditions. It works by suppressing the immune response and inflammatory processes at the site of application.

Peso Molecular

494,6000 g/mol

LogP

3,90

TPSA

101,00 Å²

Regra dos 5 de Lipinski

Aprovado

Mecanismo de Ação

Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mecanismo

Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.

Estrutura 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C(C)(C)C

InChI

InChI=1S/C27H36F2O6/c1-14-9-16-17-11-19(28)18-10-15(30)7-8-24(18,5)26(17,29)20(31)12-25(16,6)27(14,34)21(32)13-35-22(33)23(2,3)4/h7-8,10,14,16-17,19-20,31,34H,9,11-13H2,1-6H3/t14-,16+,17+,19+,20+,24+,25+,26+,27+/m1/s1

Molecular Formula

C27H36F2O6

HBD / HBA

2 / 8

Ligações Rotacionáveis

5

Átomos Pesados

35

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

This topical corticosteroid is applied to the skin or used in ear preparations to reduce inflammation, itching, and redness associated with inflammatory skin or ear conditions. It works by suppressing the immune response and inflammatory processes at the site of application.

Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.

Yes, Flumethasone Pivalate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200877. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 443980. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Procura informações acessíveis para o paciente?

Flumethasone Pivalate no PillFYI

Estrutura

Dados Rápidos

Fórmula: C27H36F2O6

Links Externos

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.

Flumethasone Pivalate

Mecanismo de Ação

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estrutura 2D

Cite this structure

Embed this structure

No targets recorded

No interactions recorded

No side effects recorded

Perguntas frequentes

References & Data Sources

Embed This Widget